Share price increase follows Biotron's HIV success
28 May, 2002 by Melissa TrudingerCanberra biotech Biotron has announced that its lead anti-HIV compound, BIT009 has shown inhibition of HIV-1 replication in infected human cells.
Tocovite claims its technology delivers
27 May, 2002 by Melissa TrudingerMelbourne-based company Tocovite claims an absorption system that it has developed could improve drug delivery through the skin.
US man first to receive Sirtex cancer treatment
24 May, 2002 by Iain ScottAnti-cancer treatment SIR-Spheres, designed by Sydney-based company Sirtex, has been used on a patient for the first time since it received US Food and Drug Administration (FDA) approval in March this year.
Diabetes research offensive launched
24 May, 2002 by Tanya HollisA research and development agreement with the aim of finding an effective treatment for type II diabetes has been signed in Melbourne.
Melbourne researchers discover heart attack gene link
24 May, 2002 by Melissa TrudingerAustralian researchers have determined three genetic loci which are linked to heart attacks.
UQ researchers in bone growth breakthrough
15 May, 2002 by Pete YoungAustralian research on sugars which stimulate stem cells to become bone tissue has resulted in a biological paste that promotes healing of fractures and breaks.
Sleep disorder treatments could help heart patients
15 May, 2002 by Daniella GoldbergCardiologists may be prescribing sleep disorder treatments to their patients in the next five years, according to reports from the 14th World Congress of Cardiology, held recently in Sydney.
Epilepsy discoveries expand Bionomics patent portfolio
14 May, 2002 by Tanya HollisSouth Australian genomics company Bionomics has expanded its portfolio of potential epilepsy drug targets with the filing of eight new patents.
Mass spec diagnostic developed for ovarian cancer
09 May, 2002 by Tanya HollisMass spectrometry is helping Melbourne researchers develop a diagnostic test for the early detection of ovarian cancer.
Skin cancer device launched
08 May, 2002 by Daniella GoldbergA device for the early detection of skin cancer has been launched by Sydney-based medical device company, Polartechnics.
Support for Prana Alzheimer's treatment
03 May, 2002 by Daniella GoldbergPrana Biotechnology's theory for treating Alzheimer's disease with zinc-targeted drugs has won support from a paper published this week in the Proceedings of the National Academy of Science.
Starpharma STD gel in US tests
02 May, 2002 by Tanya HollisThe US government is paying for tests of a Melbourne-developed microbicide gel on macaque monkeys.
Progen's cancer drug in trials
01 May, 2002 by Daniella GoldbergBrisbane based Progen Industries has moved into Phase II clinical trials for their small molecule cancer drug PI-88.
Peplin researches pancreas
29 April, 2002 by Iain ScottPeplin Biotech has broadened its research pipeline for anti-cancer drugs that target diseases of the pancreas.
AGRF participates in schizophrenia study
26 April, 2002 by Melissa TrudingerThe Australian Genome Research Facility (AGRF) has played a crucial role in a major international study on the genetic causes of schizophrenia.
